155 related articles for article (PubMed ID: 16437641)
1. Serum arylesterase and paraoxonase activity in patients with chronic hepatitis.
Kilic SS; Aydin S; Kilic N; Erman F; Aydin S; Celik I
World J Gastroenterol; 2005 Dec; 11(46):7351-4. PubMed ID: 16437641
[TBL] [Abstract][Full Text] [Related]
2. Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B.
Mogarekar MR; Talekar SJ
Indian J Gastroenterol; 2013 Sep; 32(5):307-10. PubMed ID: 23700138
[TBL] [Abstract][Full Text] [Related]
3. Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.
Keskin M; Dolar E; Dirican M; Kiyici M; Yilmaz Y; Gurel S; Nak SG; Erdinc S; Gulten M
Intern Med J; 2009 Apr; 39(4):243-8. PubMed ID: 19402863
[TBL] [Abstract][Full Text] [Related]
4. Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population.
Schwedhelm C; Nimptsch K; Bub A; Pischon T; Linseisen J
Br J Nutr; 2016 Feb; 115(4):730-6. PubMed ID: 26769660
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant status in blood of obese children: the relation between trace elements, paraoxonase, and arylesterase values.
Cayir Y; Cayir A; Turan MI; Kurt N; Kara M; Laloglu E; Ciftel M; Yildirim A
Biol Trace Elem Res; 2014 Aug; 160(2):155-60. PubMed ID: 24920129
[TBL] [Abstract][Full Text] [Related]
6. Correlation of serum arylesterase activity on phenylacetate estimated by the integrated method to common classical biochemical indexes of liver damage.
Liao F; Zhu XY; Wang YM; Zhao YS; Zhu LP; Zuo YP
J Zhejiang Univ Sci B; 2007 Apr; 8(4):237-41. PubMed ID: 17444597
[TBL] [Abstract][Full Text] [Related]
7. Oxidant and antioxidant of arylesterase and paraoxonase as biomarkers in patients with hepatitis C virus.
Ali EM; Shehata HH; Ali-Labib R; Esmail Zahra LM
Clin Biochem; 2009 Sep; 42(13-14):1394-400. PubMed ID: 19538950
[TBL] [Abstract][Full Text] [Related]
8. The activities of serum paraoxonase and arylesterase and lipid profile in acute myeloid leukemia: preliminary results.
Çebi A; Akgun E; Esen R; Demir H; Çifci A
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4590-4. PubMed ID: 26698256
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum paraoxonase and arylesterase activities in subjects with asthma and chronic obstructive lung disease.
Acay A; Erdenen F; Altunoglu E; Erman H; Muderrisoglu C; Korkmaz GG; Gelisgen R; Tabak O; Uzun H
Clin Lab; 2013; 59(11-12):1331-7. PubMed ID: 24409668
[TBL] [Abstract][Full Text] [Related]
10. Acetaminophen intoxication is associated with decreased serum paraoxonase and arylesterase activities and increased lipid hydroperoxide levels.
Karadas S; Aslan M; Gonullu H; Kati C; Duran L; Olmez S; Kucukoglu ME; Demir H
Hum Exp Toxicol; 2014 Nov; 33(11):1134-40. PubMed ID: 24501102
[TBL] [Abstract][Full Text] [Related]
11. Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B.
Karsen H; Binici I; Sunnetcioglu M; Baran AI; Ceylan MR; Selek S; Celik H
Afr Health Sci; 2012 Jun; 12(2):114-8. PubMed ID: 23056015
[TBL] [Abstract][Full Text] [Related]
12. Serum lipid profile paraoxonase and arylesterase activities in psoriasis.
Toker A; Kadi M; Yildirim AK; Aksoy H; Akçay F
Cell Biochem Funct; 2009 Apr; 27(3):176-80. PubMed ID: 19330810
[TBL] [Abstract][Full Text] [Related]
13. PON1 status in haemodialysis patients and the impact of hepatitis C infection.
Horoz M; Aslan M; Selek S; Koylu AO; Bolukbas C; Bolukbas FF; Celik H; Erel O
Clin Biochem; 2007 Jun; 40(9-10):609-14. PubMed ID: 17335792
[TBL] [Abstract][Full Text] [Related]
14. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.
Elkiran ET; Mar N; Aygen B; Gursu F; Karaoglu A; Koca S
BMC Cancer; 2007 Mar; 7():48. PubMed ID: 17362500
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients.
Saeed SA; Elsharkawy M; Elsaeed K; Fooda O
Hemodial Int; 2008 Oct; 12(4):471-9. PubMed ID: 19090870
[TBL] [Abstract][Full Text] [Related]
16. Levels of paraoxonase and arylesterase activities and malondialdehyde in workers exposed to ionizing radiation.
Serhatlioglu S; Gursu MF; Gulcu F; Canatan H; Godekmerdan A
Cell Biochem Funct; 2003 Dec; 21(4):371-5. PubMed ID: 14624476
[TBL] [Abstract][Full Text] [Related]
17. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O
Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543
[TBL] [Abstract][Full Text] [Related]
18. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis.
Aslan M; Horoz M; Nazligul Y; Bolukbas C; Bolukbas FF; Selek S; Aksoy N; Erel O
Int J Clin Pract; 2008 Jul; 62(7):1050-5. PubMed ID: 17887991
[TBL] [Abstract][Full Text] [Related]
19. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
20. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
Dirican M; Akca R; Sarandol E; Dilek K
J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
